KalVista Pharmaceuticals, Inc. ($KALV)
Piekos Brian โ Chief Financial Officer
Shares
6,250
Price
$0.00
Total Value
$0.00
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Piekos Brian |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | Apr 16, 2026 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Apr 20, 2026 |
| Shares Purchased | 6,250 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 20,012 |
| Derivative | No |
| Accession Number | 0001815308-26-000003 |
| Document | View SEC Filing |